Does the use of Rabenda-Plus lead to increased risk of fractures?
Nov 4, 2023
Does the use of Rabenda-Plus lead to increased risk of fractures?
Multiple studies conducted in adults have revealed a potential link between the administration of RabendaPlus and a heightened probability of experiencing fractures related to osteoporosis in areas such as the hip wrist or spine Notably this increased risk has been observed in patients who were subjected to high doses of the medication The term high dose encompasses the concept of receiving numerous daily doses of the drug as well as undergoing longterm treatment extending over a year or more These findings have raised concerns about the safety implications associated with the use of RabendaPlus in the management of certain conditions in adults It is vital for healthcare providers to carefully assess the benefits and potential risks before deciding to prescribe this medication to patients particularly those who may be susceptible to osteoporosisrelated fractures Taking into consideration the evidence from various studies it is imperative to employ caution and closely monitor individuals receiving RabendaPlus to mitigate the likelihood of such fractures occurring Further research and analysis are warranted to gain a deeper understanding of the relationship between RabendaPlus and its potential adverse effects on bone health ultimately leading to safer therapeutic interventions
Medicines
For information purposes only. Consult a doctor before taking any medicines.
₹130₹260
₹237₹263
₹144₹160
₹189₹210
₹328₹365
₹146₹162
₹255₹283
₹111₹123
₹149₹165